Gene Vector
About:
Gene Vector is an AAV gene therapy new drug research and development company.
Website: http://www.jwksw.com/
Top Investors: Yingke Capital, Ruijing Investment, Sichuan Huisu, Ming capital, Wuhan East Lake High Technology
Description:
Chengdu Genevector Biotechnology Co., Ltd. (Genevector, Genevector) is a biotechnology company engaged in the research and development of new drugs for adeno-associated virus (AAV) gene therapy. The company is committed to the development of new AAV gene therapy drugs for ophthalmic diseases, neuromuscular diseases, genetic and metabolic diseases, etc.
Total Funding Amount:
$3.16M
Headquarters Location:
Chengdu, Sichuan, China
Founded Date:
2017-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2022-11-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai